Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

27.98

+1.15 (4.29%)

At close: Nov 6, 2026, 4:00 PM EST

27.51

-0.47 (-1.68%)

After-hours: Nov 6, 2026, 7:30 PM EST

Adaptive Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	75.62	70.5	47.92	65.06	90.03	139.07
Short-Term Investments	223.34	156.49	174.37	281.34	408.17	214
Cash & Short-Term Investments	298.95	226.98	222.29	346.4	498.2	353.06
Cash Growth	40.51%	2.11%	-35.83%	-30.47%	41.11%	-48.70%
Accounts Receivable	66.67	50.37	41.73	37.97	40.06	17.41
Other Receivables	2.6	1.5	1.3	1	0.8	1.4
Receivables	69.27	51.87	43.03	38.97	40.86	18.81
Inventory	10.06	9.82	8.44	14.45	14.45	19.26
Prepaid Expenses	14.41	11.52	9.99	10.37	8.64	11.62
Total Current Assets	392.69	300.19	283.75	410.19	562.15	402.75
Property, Plant & Equipment	65.96	74.72	94.38	120.32	164.21	172.94
Long-Term Investments	101.23	13.23	33.66	-	-	217.15
Goodwill	118.97	118.97	118.97	118.97	118.97	118.97
Other Intangible Assets	0.46	1.73	3.43	5.13	6.83	8.53
Other Long-Term Assets	3.82	3.9	5.18	6.52	4.46	3.01
Total Assets	683.12	512.74	539.38	661.13	856.62	923.34

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.53	6.47	7.27	7.72	8.08	3.31
Accrued Expenses	23.31	22.72	20.67	20.39	24.1	22.2
Current Portion of Long-Term Debt	-	4.64	0.87	-	-	-
Current Portion of Leases	9.14	8.92	10.24	9.38	9.23	5.06
Current Income Taxes Payable	-	0.54	0.18	0.06	0.19	0.39
Current Unearned Revenue	60	45.19	55.69	48.63	64.12	80.46
Other Current Liabilities	-	1.43	3.15	1.84	4.07	2.39
Total Current Liabilities	98.97	89.92	98.05	88.02	109.79	113.81
Long-Term Debt	335.38	126.57	132.41	130.66	125.36	-
Long-Term Leases	64.46	70.23	79.15	89.39	98.77	106.69
Long-Term Unearned Revenue	0.41	1.01	27.26	44.79	58.6	98.75
Other Long-Term Liabilities	0.02	0.02	0.02	-	-	-
Total Liabilities	499.23	287.74	336.89	352.86	392.52	319.24

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,598	1,582	1,506	1,453	1,387	1,324
Retained Earnings	-1,420	-1,363	-1,304	-1,144	-919.08	-718.89
Comprehensive Income & Other	-1.29	0.25	0.17	0.22	-4.12	-1.14
Total Common Equity	176.21	218.79	202.71	308.4	464.17	603.99
Minority Interest	7.68	6.21	-0.22	-0.12	-0.07	0.11
Shareholders' Equity	183.89	225	202.49	308.28	464.1	604.1
Total Liabilities & Equity	683.12	512.74	539.38	661.13	856.62	923.34

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	408.97	210.36	222.67	229.43	233.36	111.74
Net Cash (Debt)	-8.79	29.86	33.29	116.97	264.83	458.47
Net Cash Growth	-	-10.30%	-71.54%	-55.83%	-42.23%	-34.41%
Net Cash Per Share	-0.06	0.20	0.23	0.81	1.86	3.27
Filing Date Shares Outstanding	161.88	153.98	148.58	145.09	143.23	141.58
Total Common Shares Outstanding	161.57	153.78	147.77	145.08	143.11	141.39
Working Capital	293.72	210.27	185.7	322.17	452.36	288.94
Book Value Per Share	1.09	1.42	1.37	2.13	3.24	4.27
Tangible Book Value	56.79	98.1	80.31	184.3	338.37	476.49
Tangible Book Value Per Share	0.35	0.64	0.54	1.27	2.36	3.37
Machinery	-	54.39	59.33	61.36	56.7	48.88
Construction In Progress	-	1.1	2.57	3.41	7.63	5.66
Leasehold Improvements	-	73.11	73.28	74.73	72.4	65.96

SEC Filings: 10-K · 10-Q